Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Research updates on the role of hepcidin in chronic viral hepatitis
- Yang N. , et al.
2. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation
- Ohta K. , et al.
3. Polymorphisms Related to Iron Homeostasis Associate with Liver Disease in Chronic Hepatitis C
- Wróblewska A. , et al.
4. Iron as a therapeutic target in chronic liver disease
- Kouroumalis E. , et al.
5. Synergistic Antiviral Effects of Metal Oxides and Carbon Nanotubes
- Gupta I. , et al.
6. Review article: iron disturbances in chronic liver diseases other than haemochromatosis – pathogenic, prognostic, and therapeutic implications
- Czaja A.J. , et al.
7. Iron and liver fibrosis: Mechanistic and clinical aspects
- Mehta K.J. , et al.
8. Importance of studying the levels of hepcidin and Vitamin D in Egyptian children with chronic hepatitis C
- Mohamed A.A. , et al.
9. Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C
- Sato M. , et al.
10. Predictive value of hepcidin in patients with chronic hepatitis C infection among Egyptians
- Ismail H.A. , et al.
11. Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C
- Rogalska-Taranta M. , et al.
13. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C
- Wróblewska A. , et al.
14. Relationship between hepatitis C virus infection and iron overload
- Zou D.M. , et al.
15. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis
- Sikorska K. , et al.
16. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency
- Foka P. , et al.
17. The iron homeostasis network and hepatitis C virus – a new challenge in the era of directly acting antivirals
- Sikorska K. , et al.